We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

20 hedge funds and large institutions have $959K invested in EnteroMedics Inc. in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

110% more capital invested

Capital invested by funds: $457K → $959K (+$502K)

17% less funds holding

Funds holding: 2420 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $7K

Holders
20
Holders Change
-4
Holders Change %
-16.67%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
1
Closed
7
Calls
Puts
$7K
Net Calls
-$7K
Net Calls Change
+$8K

ETRM Hedge Fund Activity: Q3 2016 in Review

20 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q3 2016, worth a combined $959K — up 110% from $457K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ETRM and 3 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, adding an estimated $714K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $130K sold.

  • 20 institutional investors held EnteroMedics Inc. (ETRM) as of Q3 2016, down from 24 in Q2 2016.
  • Funds reported $959K of EnteroMedics Inc. stock for Q3 2016, up 110% quarter-over-quarter.
  • 3 funds opened new EnteroMedics Inc. positions in Q3 2016 and 7 closed out, a net change of -4 holders.
  • The largest EnteroMedics Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $714K added.
  • The largest EnteroMedics Inc. seller in Q3 2016 was Hudson Bay Capital Management, an estimated $130K sold.

Based on aggregated 13F filings for Q3 2016.